Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

3.8K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Fully Human Engineered Bone Niche With Endogenous Osteoclastogenesis Reveals Osteoclast-Dependent Osteomimicry in Prostate Cancer Cells.

Advanced healthcare materials·2026
Same author

A Vascularized Microphysiological System Reproducing Endochondral Ossification in Vitro to Study Ewing Sarcoma Proliferation and Migration.

Advanced functional materials·2026
Same author

Clinical Impact of Myocardium at Risk in Transcatheter Aortic Valve Implantation.

Circulation. Cardiovascular interventions·2026
Same author

Role of external forces in the mechanobiology of stem and differentiated chondrogenic cells embedded in a tissue-engineered construct for cartilage repair.

Journal of biomedical science·2026
Same author

Migration and Chondrogenesis of Cells from Minced Nasal Cartilage in Type I Collagen Hydrogel: A Workflow for One-Step Engineering of Injectable Grafts.

Gels (Basel, Switzerland)·2026
Same author

Modular de- and re-construction of vascularized osteochondral tissues in an Organ-on-Chip dual-compartment platform.

Journal of orthopaedic translation·2026
Same journal

Cationic nanotrap curbs UVB-induced cutaneous photodamage via exosomal cfNA capture.

Biomaterials·2026
Same journal

A protein-initiated polymerization cascade enables a self-eliminating powder tissue adhesive for diabetic ulcer repair.

Biomaterials·2026
Same journal

Oral colon-targeted micro-nano formulation engineered in microfluid for synergistic therapy of inflammatory bowel disease.

Biomaterials·2026
Same journal

Manganese@Gold cluster-coordinated covalent organic frameworks-based artificial metalloenzymes with cascade biocatalysis and amplified systemic stimulation to combat malignant tumor metastasis.

Biomaterials·2026
Same journal

Remodeling TME via feedback-driven photothermal-ferroptosis-immune cascade.

Biomaterials·2026
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
See all related articles

Related Experiment Video

Updated: Dec 15, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

3.8K

Engineered human osteoarthritic cartilage organoids.

Laura Dönges1, Atharva Damle1, Andrea Mainardi1

  • 1Department of Biomedicine, University Hospital Basel, University of Basel, 4031, Basel, Switzerland.

Biomaterials
|March 30, 2024
PubMed
Summary
This summary is machine-generated.

Researchers developed a human osteoarthritis (OA) cartilage organoid model to study disease mechanisms. This model identified C/EBPβ as a key factor in OA progression, offering a new target for developing disease-modifying osteoarthritis therapies.

Keywords:
C/EBPβCartilage organoidsIL1RaInflammation

More Related Videos

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation
12:37

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

20.1K
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

20.8K

Related Experiment Videos

Last Updated: Dec 15, 2025

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs
12:44

Creation of a Knee Joint-on-a-Chip for Modeling Joint Diseases and Testing Drugs

Published on: January 27, 2023

3.8K
3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation
12:37

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

20.1K
A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid
09:58

A 3D System for Culturing Human Articular Chondrocytes in Synovial Fluid

Published on: January 31, 2012

20.8K

Area of Science:

  • Biomedical Engineering
  • Cartilage Biology
  • Osteoarthritis Research

Background:

  • Osteoarthritis (OA) poses a significant unmet clinical need, necessitating advanced models for therapeutic development.
  • Current human cell-based models struggle to fully recapitulate OA's complex molecular pathology.

Purpose of the Study:

  • To engineer a human organotypic cartilage model that mimics key OA pathological features.
  • To utilize this model for identifying novel molecular drivers and therapeutic targets in OA.

Main Methods:

  • Mesenchymal stromal cells were subjected to inflammatory challenges during chondrogenesis to create organoids.
  • Engineered OA cartilage organoids were treated with IL-1Ra, followed by mass spectrometry-based proteomics.
  • Inhibition of specific kinases activating CCAAT/enhancer-binding protein beta (C/EBPβ) was investigated.

Main Results:

  • The engineered model successfully recapitulated OA hallmarks: chondrocyte hypertrophy, matrix mineralization, enhanced catabolism, and mechanical stiffening.
  • IL-1Ra treatment significantly reduced C/EBPβ production.
  • Inhibiting C/EBPβ-activating kinases reversed OA-associated degradative processes.

Conclusions:

  • Human OA cartilage organoids provide a relevant platform for discovering OA molecular drivers.
  • This model facilitates the assessment of novel therapeutics targeting OA pathways.
  • Targeting C/EBPβ and its activating kinases shows promise for OA treatment.